This drug can inhibit GCs cell autophagy and promote follicle development to alleviate ovulation disorders in PCOS combined with IR rats, which is associated with the activation of PI3K/AKT/mTOR signaling pathway by the drug (74). Here, MTOR is linked to polycystic ovary syndrome.